What is the risk of a baby inheriting Sickle Cell Disease (SCD) or Sickle Cell (SC) trait if the father has the SC trait and the mother has not been tested and has no family history of SCD?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Assessment for Baby with Father Having Sickle Cell Trait

The risk is low and becomes nil if the mother tests negative for sickle cell trait or disease (Answer D). This is the most appropriate answer because sickle cell disease requires inheritance of two abnormal hemoglobin genes—one from each parent—and if the mother lacks any sickle cell gene, the baby cannot develop sickle cell disease 1.

Genetic Inheritance Pattern

Sickle cell disease follows autosomal recessive inheritance, meaning both parents must contribute an abnormal hemoglobin gene for a child to have the disease 1. The father's sickle cell trait (AS genotype) means he carries one normal hemoglobin gene and one sickle hemoglobin gene 2.

Risk Scenarios Based on Mother's Status:

  • If mother tests negative (AA genotype): The baby has 0% risk of sickle cell disease but 50% chance of inheriting sickle cell trait from the father 1, 2

  • If mother has sickle cell trait (AS genotype): The baby has 25% risk of sickle cell disease (SS), 50% chance of trait (AS), and 25% chance of normal hemoglobin (AA) 1

  • If mother has sickle cell disease (SS genotype): The baby has 50% risk of sickle cell disease and 50% chance of trait—though this scenario is unlikely given no family history 1

Critical Importance of Maternal Testing

Maternal hemoglobin testing is essential before providing definitive counseling 2. The absence of family history of sickle cell disease in the mother's family is reassuring but does not eliminate carrier status, as:

  • Many individuals with sickle cell trait are asymptomatic and unaware of their status 3
  • Less than half of women know their trait status before their first pregnancy 3
  • Carrier frequency varies significantly by ethnicity and geographic ancestry 2

Clinical Recommendations

The couple should proceed with maternal hemoglobin electrophoresis or HPLC testing immediately 1, 2. This simple blood test will:

  • Definitively establish the baby's risk level
  • Allow for informed reproductive planning
  • Enable appropriate prenatal counseling if both parents are carriers 1

If both parents are found to be carriers, prenatal diagnostic options include 1:

  • Chorionic villus sampling (CVS) at 10-13 weeks
  • Amniocentesis at 15-20 weeks
  • Preimplantation genetic diagnosis with in vitro fertilization

Important Counseling Points

The father's brothers having sickle cell disease confirms that both of the father's parents are at minimum carriers, which is consistent with the father having trait 1. However, this family history does not increase the baby's risk beyond what the parental genotypes determine 1.

Advising against having children (Answer C) is inappropriate without knowing the mother's status and would only be considered if both parents are carriers and they choose not to accept the 25% disease risk after comprehensive genetic counseling 1, 2.

The answer "high risk" (Answer A) is incorrect because risk cannot be characterized as high when there is a substantial probability the mother is not a carrier 2. The answer "no risk" (Answer B) is incorrect because risk exists until maternal testing excludes carrier status 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.